Dapagliflozin
Metformin
Medicine
Sulfonylurea
Incremental cost-effectiveness ratio
Type 2 diabetes
Per capita
Internal medicine
Diabetes mellitus
Cost effectiveness
Quality-adjusted life year
Environmental health
Insulin
Endocrinology
Population
Risk analysis (engineering)
